Herman Sullivan MD MD (He/Him)
Neuroimmunology/Multiple Sclerosis
Executive Medical Director Hauenstein Neurosciences Medical Director, Multiple Sclerosis Clinic at Trinity Health GR
Join to View Full Profile
200 Cherry St SEGrand Rapids, MI 49503
Phone+1 616-685-5050
Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health CareFellowship, 1989 - 1991
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1986 - 1989
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1985 - 1986
University of North Carolina at Chapel Hill School of MedicineClass of 1985
Harvard UniversityBS, Biochemical Sciences and Molecular Biology, 1977 - 1981
Certifications & Licensure
MI State Medical License 1996 - 2025
OH State Medical License 1991 - 1996
CA State Medical License 1989 - 1991
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Clinical Trial Nuedexta in Subjects With ALS Start of enrollment: 2013 Apr 01
- Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409 Start of enrollment: 2015 Jan 07
- Join now to see all
Publications & Presentations
PubMed
- 189 citationsAlemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical TrialAlasdair Coles, Edward Fox, A. Vladic, Suzanne Gazda, Vesna V. Brinar
Neurology. 2012-04-03 - 39 citationsA single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosisEdward Fox, H. C. Sullivan, Suzanne Gazda, Lori Mayer, L. O'Donnell
European Journal of Neurology. 2012-02-01 - 107 citationsLinomide in relapsing and secondary progressive MS Part II: MRI resultsJerry S. Wolinsky, Ponnada A. Narayana, John H. Noseworthy, Fred D. Lublin, John N. Whitaker
Neurology. 2000-05-09
Professional Memberships
- Member
- Member
- Member
Industry Relationships
- Medical Director, Pharmcia & UpjohnMedical director for several chemical entities in various stages of development, including pramipexole (Parkinson disease), almotriptan (migraine), and linomide (multiple sclerosis).Disclosure: None currently1995 - 1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
